Agilent Technologies stock heads into the open after a 3.3% gain
Published on 09/22/2026 at 04:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Agilent Technologies stock closed at USD 161.62 on its US listing on September 21, 2026, up 3.3% from the prior session. The advance outpaced the broader market, with the S&P 500 gaining about 1.5% on the same day.
September 21, 2026 in numbers
Agilent Technologies Inc. (ISIN US00846U1016, NYSE: A) saw its shares finish the September 21, 2026 session at USD 161.62, compared with a prior close of USD 156.47, implying a 3.3% daily gain per NYSE data. According to MarketScreener, Goldman Sachs raised its price target on Agilent Technologies to USD 185 from USD 175 while maintaining a buy rating in a note published on September 21, 2026, which provided a clear positive catalyst for the stock. The same report cited a last close of USD 156.47 for Agilent Technologies before the move, highlighting the step up in valuation implied by the new target. In the wider market, preliminary figures reported by Livemint showed the S&P 500 closing up roughly 1.49% and the Nasdaq Composite up 2.26% on September 21, 2026, underscoring that Agilent’s gain slightly exceeded the broader index move while broadly tracking the positive tone in US equities.
Today’s focus for Agilent Technologies
Today, September 22, 2026, Agilent Technologies enters the US session with that higher price base and a fresh endorsement from Goldman Sachs, which may keep attention on the stock as investors weigh the new USD 185 target against the latest close. The same MarketScreener note indicates that Agilent Technologies has a quarterly dividend of USD 0.255 per share, with an ex-dividend date set for October 6, 2026, meaning dividend-focused investors will be watching the stock in the coming days as that date approaches.MarketScreener In the broader backdrop, US indices are coming off a strong technology-led rally, described by Yahoo Finance as driven by gains in chip stocks and a rebound in risk appetite, a context that can influence sentiment toward life-science and diagnostics names such as Agilent Technologies as investors rebalance portfolios ahead of upcoming economic data and earnings updates.
